Managing a patient with diabetes receiving systemic glucocorticoids

Area of Science:

• Endocrinology
• Pharmacology
• Diabetes Management

Background:

• Systemic glucocorticoids are frequently prescribed for various inflammatory and autoimmune conditions.
• Glucocorticoid therapy is known to significantly impact glucose metabolism, posing challenges for patients with diabetes.
• There is a recognized gap in evidence-based guidelines for managing diabetes in patients concurrently receiving systemic glucocorticoids.

Purpose of the Study:

• To consolidate and present therapeutic recommendations for managing patients with diabetes who are undergoing systemic glucocorticoid therapy.
• To address the clinical need for evidence-based strategies in this specific patient population.

Main Methods:

• This article is a review and synthesis of existing literature and clinical expertise.
• It focuses on therapeutic strategies relevant to glycemic control and management of diabetes complications during glucocorticoid use.

Main Results:

• Systemic glucocorticoids can induce hyperglycemia, worsen glycemic control, and increase the risk of diabetic complications.
• Recommendations include intensified glycemic monitoring, potential adjustments to antidiabetic medications, and consideration of lifestyle modifications.
• Close collaboration between endocrinologists and prescribing physicians is crucial.

Conclusions:

• Effective management of diabetes during systemic glucocorticoid therapy is achievable with tailored strategies.
• Adherence to recommended guidelines can mitigate risks and improve patient outcomes.
• Further research is warranted to strengthen the evidence base for optimal management.